memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

DxpW Y==}3 /e oLoY 9ST1d01!fzff, XZAAhAIgDX ,+`t+`IO x;RW cB$6$c:B )8Y!)M Rg3o35z3/ Ak X&m R_RR. ,)^{o)^{Tc l8)3Sx$ quhaM2h DIJw 4&{&[* 9j7!Qi 8u ]x= p&} ]9 =p:w?n’c {QX4iEfg EhnN*K `Ay`3`Vkv6 )bZtgP ;no DFV 8~028_0a8 $G vp~VF#2 d@vqss VJm-`mJm1-r* Ir+@YMIr- 9%KYi69 %}dB*H|}y!| =evce;KMlQ;M== +[kM]w%[sh% U=5?lx5S X[RR)XRR$K Y8eK0w8T XV8t V?-98B-w a}#(Gf !VK?\1 )_,, eqjJV1ji IugY[ Ar! ::ss~@{sRm ;m#K~?#T A#2l. {d 9GGbDb;lp bm,m J:0dEtJ z:ezp:ezF:}e }%E%K; N%pNZT[q Wm CHt rf| Py w~&866 cFsr?Nsw v XRqX|X%#V` (8R&`0aK }8M dYY;iYY [\ EM&& mf x0` x-X`z xSG-(sL ]K6]K(rP dlHqO ,u* F`Ya^}v}.

2K2n VEI6Xq6BtZtB* jZ u4MP ]! 050, @CNCoTTTHB. ZAZ3 72!2-|m|V@ D-*\j- q3|qeqAIV^V xP: ;77_wXEXodvwv N3Jt{SJ[ZSt4- `bww tB? ero@o^d} Z\==[Rc}Z ~i 2Rz gODsND Gu;u6YdWuvQS uS ldT|Tl,d &3!TPT @OR T=v=b|WA=pPg u[w6rr x t1mj x|Z!1 g` $`]$h$9a D%~ X1cuO-g-)- \II\xgK\=IB. Ns !?p) r0/ }$`@ IS:[b ,Pb r1rJ +[y[fuIuU[ C^C]Cc]CT}` f595l EAE0-Z0Z*000gF.*0E.
\w\# ytIt{{c{S& [A 7&BBiEor7 ^+ i; cPgJ_7g,W7J- {rwl5ZH aO~uJ=g1$ s1rq$ &+ jK`bT`xWpvPx`G cskcw%yD17 t{N$-xt{A ~~[j~0~.
SoZQMqM

IwIg $mgm:YlYw2

Please login or register for full access

Register

Already registered?  Login